by Team Small News | May 24, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals has announced its financial results for the fourth quarter and full year ended March 2025, highlighting a solid profit growth despite increasing interest costs. The company’s performance was driven by robust sales across its key markets... by Team Small News | May 15, 2025 | Glenmark, Pharma
The Department of Transfusion Medicine at PGIMER, Chandigarh, recently conducted two blood donation camps in the city, with the goal of ensuring an adequate blood supply for patients in need. The first camp was held on May 14, 2025, at the Community Center in... by Team Small News | May 14, 2025 | Glenmark, Pharma
NIVEA India has appointed Akshay Kawale as the Business Unit Head of its Derma division, effective April 3, 2025. Kawale brings 16 years of experience in the industry, having worked with prominent organizations such as Glenmark Pharmaceuticals, Abbott, GSK, and... by Team Small News | May 6, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals’ subsidiary, Ichnos Glenmark Innovation (IGI), has received a “fast track” designation from the United States Food and Drug Administration (USFDA) for its investigational therapy, ISB 2001. This therapy is intended for the... by Team Small News | Apr 30, 2025 | Glenmark, Pharma
The UK Court of Appeal has overturned an earlier decision, granting AstraZeneca’s request for an injunction against Glenmark Pharmaceuticals’ generic version of the diabetes treatment Forxiga (dapagliflozin). This decision comes as a significant setback...
by Team Small News | Apr 15, 2025 | Glenmark, Pharma, Sun Pharma, Zydus
Three major Indian pharmaceutical companies, Sun Pharma, Zydus, and Glenmark, have issued recalls of their products in the United States due to manufacturing issues. The recalls were announced by the US Food and Drug Administration (FDA) and cover a range of products,...